These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 4358293)

  • 21. [Hypolipemic agents].
    Paoletti R; Fumagalli R; Sirtori R
    Minerva Med; 1973 Apr; 64(24):1267-75. PubMed ID: 4707410
    [No Abstract]   [Full Text] [Related]  

  • 22. Current views on cholesterol metabolism.
    Miettinen TA
    Horm Metab Res; 1974; Suppl 4():37-44. PubMed ID: 4608004
    [No Abstract]   [Full Text] [Related]  

  • 23. The metabolism of the apoprotein of plasma low density lipoprotein in familial hyperbetalipoproteinaemia in the homozygous form.
    Simons LA; Reichl D; Myant NB; Mancini M
    Atherosclerosis; 1975; 21(2):283-98. PubMed ID: 165827
    [No Abstract]   [Full Text] [Related]  

  • 24. Plasma lipoprotein metabolism in familial lecithin:cholesterol acyltransferase deficiency.
    Glomset JA; Norum KR; Nichols AV; Forte T; King WC; Albers J; Mitchell CD; Applegate KR; Gjone E
    Scand J Clin Lab Invest Suppl; 1974; 137():165-72. PubMed ID: 4367614
    [No Abstract]   [Full Text] [Related]  

  • 25. Relationship between metabolism and composition of low density lipoproteins in rabbits on semi-purified diet.
    Lacombe C; Nibbelink M
    Artery; 1983; 11(4):273-82. PubMed ID: 6615244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pathogenesis of hyperlipoproteinemias].
    Müller G
    Z Gesamte Inn Med; 1974 Jun; 29(12):469-76. PubMed ID: 4368206
    [No Abstract]   [Full Text] [Related]  

  • 27. [Genetic aspects of lipid metabolism disorders].
    Fuhrmann W
    Verh Dtsch Ges Inn Med; 1974; 80():981-9. PubMed ID: 4375908
    [No Abstract]   [Full Text] [Related]  

  • 28. The familial dyslipoproteinemias.
    Lees RS; Wilson DE; Schonfeld G; Fleet S
    Prog Med Genet; 1973; 9():237-90. PubMed ID: 4351407
    [No Abstract]   [Full Text] [Related]  

  • 29. [Hypolipidemic effect of cholestyramine in patients affected by type II hyperlipoproteinemia].
    Sauvanet JP; Drouin P; Mejean L; Lambert D; Debry G
    Therapie; 1978; 33(5):615-22. PubMed ID: 217121
    [No Abstract]   [Full Text] [Related]  

  • 30. Cholestyramine, clofibrate and nicotinic acid as single or combined treatment of type IIa and IIb hyperlipoproteinaemia.
    Orö L; Olsson AG; Rössner S; Carlson LA
    Postgrad Med J; 1975; 51(8):suppl 76-81. PubMed ID: 215986
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Receptor-mediated control of cholesterol metabolism.
    Brown MS; Goldstein JL
    Science; 1976 Jan; 191(4223):150-4. PubMed ID: 174194
    [No Abstract]   [Full Text] [Related]  

  • 32. [Primary prevention of coronary disease by modification of the lipids].
    Augustin J
    Dtsch Med Wochenschr; 1984 Jun; 109(24):965-7. PubMed ID: 6376043
    [No Abstract]   [Full Text] [Related]  

  • 33. Cholesterol metabolism.
    Lancet; 1973 Mar; 1(7802):524-5. PubMed ID: 4119954
    [No Abstract]   [Full Text] [Related]  

  • 34. Plasma vitamin A and E levels in children with familial type II hyperlipoproteinemia during therapy with diet and cholestyramine resin.
    Glueck CJ; Tsang RC; Fallat RW; Scheel D
    Pediatrics; 1974 Jul; 54(1):51-5. PubMed ID: 4365953
    [No Abstract]   [Full Text] [Related]  

  • 35. Pediatric familial type II hyperlipoproteinemia: therapy with diet and cholestyramine resin.
    Glueck CJ; Fallat R; Tsang R
    Pediatrics; 1973 Nov; 52(5):669-79. PubMed ID: 4355362
    [No Abstract]   [Full Text] [Related]  

  • 36. [Classification and diet therapy of hyperlipemia].
    Heyden S
    Dtsch Med Wochenschr; 1974 Jan; 99(4):141-4. PubMed ID: 4358872
    [No Abstract]   [Full Text] [Related]  

  • 37. A receptor-mediated pathway for cholesterol homeostasis.
    Brown MS; Goldstein JL
    Science; 1986 Apr; 232(4746):34-47. PubMed ID: 3513311
    [No Abstract]   [Full Text] [Related]  

  • 38. [Familial hyperlipoproteinemia type III].
    Patsch JR; Patsch W; Sailer S; Braunsteiner H
    Dtsch Med Wochenschr; 1976 Oct; 101(44):1612-9. PubMed ID: 185039
    [No Abstract]   [Full Text] [Related]  

  • 39. The lipoprotein apoproteins. Their role in normal lipid transport and dyslipoproteinemia.
    Levy RI; Eisenberg S
    Ann Biol Clin (Paris); 1974; 32(1):1-8. PubMed ID: 4366057
    [No Abstract]   [Full Text] [Related]  

  • 40. Composition of low density lipoprotein in children with familial hyperbetalipoproteinaemia and the effect of treatment.
    Bagnall TF
    Clin Chim Acta; 1972 Nov; 42(1):229-33. PubMed ID: 4347579
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.